Are Pharma Imports Reddy for Trump? January 11, 2017 The latest industry to face President-elect Trump’s attention is pharmaceutical manufacturing, where a commitment has been made to cut costs. While it is not clear how this will be achieved, the U.S. has made significant use of imported generic drugs once branded versions’ patents end. Panjiva... Read more →
The Old Ones Are the Best Ones as P-PI Drug Imports Grow November 22, 2016 U.S. imports of proton-pump inhibitor drugs to treat gastrointestinal disease increased 45% in October on a year earlier, a similar rate to that seen for statins and anticonvulsants. Around half the growth in the three months to October 31 vs. the same period a year earlier came from omeprazol... Read more →